Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390854 | SCV001592719 | pathogenic | Cobalamin C disease | 2023-07-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MMACHC protein in which other variant(s) (p.Trp203*) have been determined to be pathogenic (PMID: 16311595, 20631720, 23954310, 27383490, 28327205). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1076830). This premature translational stop signal has been observed in individual(s) with cobalamin C deficiency (PMID: 33473346). This variant is present in population databases (rs398124293, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg186Tyrfs*4) in the MMACHC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 97 amino acid(s) of the MMACHC protein. |
Baylor Genetics | RCV001390854 | SCV004193177 | pathogenic | Cobalamin C disease | 2023-09-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001390854 | SCV005655376 | likely pathogenic | Cobalamin C disease | 2024-06-11 | criteria provided, single submitter | clinical testing |